Cisternal nicardipine for prevention of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a comparative retrospective cohort study

Alberto Vandenbulcke,Mahmoud Messerer,Marta Garvayo Navarro,David R. Peters,Daniele Starnoni,Lorenzo Giammattei,Nawfel Ben-Hamouda,Francesco Puccinelli,Guillaume Saliou,Giulia Cossu,Roy T. Daniel,Daniel, Roy T.

DOI: https://doi.org/10.1007/s00701-024-06023-z

2024-03-14

Acta Neurochirurgica

Abstract:Intrathecal vasoactive drugs have been proposed in patients with aneurysmal subarachnoid hemorrhage (aSAH) to manage cerebral vasospasm (CV). We analyzed the efficacy of intracisternal nicardipine compared to intraventricular administration to a control group (CG) to determine its impact on delayed cerebral ischemia (DCI) and functional outcomes. Secondary outcomes included the need for intra-arterial angioplasties and the safety profile.

surgery,clinical neurology